Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

SELL
$47.08 - $55.16 $2.21 Million - $2.58 Million
-46,839 Reduced 62.34%
28,299 $1.38 Million
Q4 2022

Feb 14, 2023

BUY
$34.17 - $47.91 $2.57 Million - $3.6 Million
75,138 New
75,138 $3.02 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Coronation Fund Managers Ltd. Portfolio

Follow Coronation Fund Managers Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coronation Fund Managers Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Coronation Fund Managers Ltd. with notifications on news.